Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Florence Tartarin"'
Autor:
Xavier Leleu, Jean-Claude Chomel, André Herbelin, Carine Motard, Stéphanie Ragot, Florence Tartarin, Anne Corby, Guillaume Denis, Jose Torregrosa-Diaz, Deborah Desmier, Thomas Systchenko, Lydia Roy, Jean-Marc Gombert, Emmanuel Fleck, Emilie Cayssials, Pilar Gallego-Hernanz, François Guilhot, Antoine Machet, Natacha Maillard
Publikováno v:
Cancer. 126:3438-3447
Background Long-term treatment-free remission (TFR) represents a new goal for chronic myeloid leukemia (CML). In clinical practice, tyrosine kinase inhibitor (TKI) dose reductions can be considered a means of preventing adverse effects and improving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb8d67792b907fc8b95c56993fd40a6d
https://doi.org/10.1002/cncr.32940
https://doi.org/10.1002/cncr.32940
Autor:
François Guilhot, Joelle Guilhot, Xavier Leleu, Emilie Cayssials, Jean-Claude Chomel, Florence Tartarin, Nathalie Sorel
Publikováno v:
Leukemia & Lymphoma. 59:766-769
Since tyrosine kinase inhibitors (TKI) have been introduced in the armamentarium of chronic myeloid leukemia (CML) therapy, CML patients can expect a life expectancy close to the healthy population...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc55e4837ad30d7db596fd1b5ab7f40
https://doi.org/10.1080/10428194.2017.1357178
https://doi.org/10.1080/10428194.2017.1357178
Autor:
Stéphanie Ragot, Céline Baudemont, Marc Paccalin, Isabelle Merlet, Evelyne Liuu, Foucaud du Boisgueheneuc, Florence Tartarin
Publikováno v:
Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 10:277-283
Contexte : Les symptomes comportementaux et psychologiques associes a la demence (SPCD) font partie de l’evolution naturelle de la maladie. Des unites cognitivo-comportementales (UCC) ont ete creees afin d’optimiser la prise en charge therapeutiq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edbd2759c7cf2a06d77f78579e759d65
https://doi.org/10.1684/pnv.2012.0366
https://doi.org/10.1684/pnv.2012.0366
Autor:
Christophe Bureau, C. Chagneau Derrode, I. Ollivier-Hourmaud, J.J. Kiladjian, Dominique Valla, Aurélie Plessier, Florence Tartarin, Christine Silvain, François Guilhot, L. Rouleau, L. Roy, O. Goria
Publikováno v:
La Revue de Médecine Interne. 34:A46-A47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::899abcc66933a8eb939e22a18dd18287
https://doi.org/10.1016/j.revmed.2013.10.063
https://doi.org/10.1016/j.revmed.2013.10.063
Publikováno v:
La Revue de Médecine Interne. 32:S147-S148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87ad47487235a3846e314620b965c1c3
https://doi.org/10.1016/j.revmed.2011.03.240
https://doi.org/10.1016/j.revmed.2011.03.240
Autor:
European LeukemiaNet, Francois Guilhot, Rudiger Hehlmann, Joerg Hasford, Philipp le Coutre, Josef Thaler, Gianantonio Rosti, Francisco Cervantes, Jesper Stentoft, Gert Ossenkoppele, Kimmo Porkka, Philippe Rousselot, Franck Nicolini, Arnon Nagler, Markus Pfirmann, Florence Tartarin, Joelle Guilhot
Publikováno v:
Blood. 108:4764-4764
The purpose of the registry is to collect existing cases of pts who failed imatinib therapy. Since the drug has been registered most of information on safety and efficacy were collected through clinical trials. Thus the true rate of failure is curren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26717eea7e674cc144d82a0aded4ee32
https://doi.org/10.1182/blood.v108.11.4764.4764
https://doi.org/10.1182/blood.v108.11.4764.4764